How “One Big Beautiful Bill” Enhances Your R&D Tax Claim
On July 4, 2025, the U.S. enacted the “One Big Beautiful Bill” (H.R. 1), a major tax package that reintroduces full expensing under Section 174, dramatically enhancing R&D tax benefits for U.S. companies
What’s Changed: Section 174 Expensing Is Entirely Back
Entire R&D expense deductions is back — companies can now fully deduct domestic R&D costs in the year incurred, reversing the post-2021 requirement to amortize over five years.
This change unlocks immediate tax relief and unlocks additional cash flow—especially vital for startups, mid‑sized innovators, and high‑growth firms.
Who Benefits the Most?
Startups & Growth Companies: Better cash flow in early stages, particularly when combining full expensing, Section 41 credits, and payroll-tax offset options.
Established R&D Firms: Simplified compliance and improved year‑end tax position.
High‑Innovation Industries: Sectors like software and hardware engineering with predominantly R&D salaries and prototyping costs will see significant upside
Retroactive Opportunities
Small businesses (≤ $31M average revenue) can amend returns for 2022–2024 or take a one-time catch-up deduction in 2025.
Larger firms automatically benefit in 2025, with the ability to accelerate unamortized expenses
Key Takeaways & Action Steps
Evaluate past filings—especially for 2022–2024 amortization.
Decide your strategy: amend returns or use 2025 catch-up.
Run the numbers—estimate your total tax benefit with full expensing.
Act quickly—the window for amending ends one year after enactment.
Bottom line
The “One Big Beautiful Bill” transforms the R&D tax landscape—turning years of amortized write-offs into immediate value. Whether you're a startup, scale-up, or mature innovator, this change could unlock significant cash flow and tax savings.
Eliminate the guesswork and let us help evaluate your specific situation. Let’s get started!
